Healthline: What we know about breakthrough monkeypox cases
UC expert says people with certain medical conditions may be less likely to be protected
The World Health Organization announced recently that breakthrough infections have been reported in people who had been vaccinated against monkeypox. Healthline reported there is limited data available on the efficacy of the JYNNEOS shot, so it will take time to understand how effective it is at preventing infection. Data from the 1980s has shown that the vaccine was at least 85% effective, however, some health experts expect that number to change in the current outbreak. One of the experts cited in the Healthline story was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Marketing + Brand
Fichtenbaum says that the vaccine has not been tested in humans to a large extent, so 85% is really a ballpark estimate.
Healthline reported the strength of people’s immune systems varies and certain individuals may not mount a strong enough immune response to avoid getting sick even if they are fully immunized.
“As always, those with immunosuppression, cancer, transplant patients, and persons with HIV who have a lower CD4+ lymphocyte count below 350 cells/mm3 would be more likely to not respond as well to vaccine and have a breakthrough infection,” Fichtenbaum said.
People older than 60 are also likely to be less protected, Fichtenbaum added.
Fichtenbaum says we are still learning about how common breakthrough infections are, and we don’t have the best track record for preventing the spread of infectious diseases during public health emergencies.
“Time will tell how many breakthroughs occur,” Fichtenbaum said.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
College of Medicine celebrates 100% match rate for Class of 2026
March 23, 2026
From local hospitals to the Mayo Clinic, the UC College of Medicine Class of 2026 achieved a 100% match rate for their residency training destinations.
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.